JD Health International Inc.
6618
Classifica tra le azioni
#1394
JD Health International Inc., functioning as an investment holding entity, runs... JD Health International Inc., functioning as an investment holding entity, runs an expansive digital healthcare platform across the People's Republic of China. The company supplies a diverse range of pharmaceutical and wellness products, such as over-the-counter and prescription medications, medical devices, and health supplements. These goods are distributed through both direct sales and an extensive online retail pharmacy network. Beyond product offerings, its comprehensive service suite includes virtual medical consultations, patient referrals to hospitals and doctors, health screening programs, genetic testing, and beauty care services. Additionally, it develops intelligent healthcare and wellness management solutions, alongside providing technical support and advertising services. The platform also facilitates access to various medical provisions, including general health examinations, cosmetic medical procedures, vaccination bookings, dental treatments, and nucleic acid testing. Incorporated in 2018 and headquartered in Beijing, People's Republic of China, JD Health International Inc. is a subsidiary of JD Jiankang Limited.
Prezzo delle azioni
$4.96
Capitalizzazione di mercato
$15.82B
Variazione (1 giorno)
-2.58%
Variazione (1 anno)
-40.00%
Paese
CN
Scambia JD Health International Inc. (6618)
Categoria
Healthcare
Ricavi di JD Health International Inc. (6618)
Ricavi nel Jun 2026 TTM: $11.37B
Secondo gli ultimi rapporti finanziari di JD Health International Inc., i ricavi attuali dell'azienda (TTM) sono pari a $11.37B. Nel 2023, l'azienda ha registrato ricavi di $7.56B un aumento rispetto a i ricavi dell'anno 2022, che erano pari a $6.78B. I ricavi rappresentano l'importo totale generato dalla vendita di beni o servizi. A differenza degli utili, le spese non vengono detratte.
Storico dei ricavi per JD Health International Inc. da 2017 a 2026
Ricavi alla fine di ogni anno
| Anno | Ricavi | Cambia |
|---|---|---|
| 2026 (TTM) | $11.37B | 42.72% |
| 2024 | $7.97B | 5.37% |
| 2023 | $7.56B | 11.61% |
| 2022 | $6.78B | 40.35% |
| 2021 | $4.83B | 62.70% |
| 2020 | $2.97B | 90.55% |
| 2019 | $1.56B | 31.11% |
| 2018 | $1.19B | 39.14% |
| 2017 | $853.51M | 0.00% |
Ricavi di aziende simili o concorrenti
| Azienda | Ricavi | Differenza nei ricavi | Il paese |
|---|---|---|---|
| $78.01B | 586.00% |
US
|
|
| - | - |
DE
|
|
| $21.81B | 91.80% |
US
|
|
| $3.89B | -65.75% |
SA
|
|
| $11.08B | -2.53% |
BR
|
